# CAREMM-001 (NCT05860036)

> A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05860036
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Institute of Hematology & Blood Diseases Hospital, China
- Conditions: Multiple Myeloma
- Interventions: anti-BCMA CAR-T; VRd
- Enrollment: 40
- Primary outcome: Safety and Tolerability
- Primary outcome: MRD-negative rate

## Indexed commentary on CAREMM-001 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 7
- YouTube: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=caremm-001-nct05860036

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05860036", "email": "<work email>"}; the inbox owner confirms by the emailed link.